CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	ProFrac Agreement	Common Stock	Treasury Stock	Additional Paid-in Capital	Additional Paid-in Capital ProFrac Agreement	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2021	$ 20,192		$ 1	$ (34,100)	$ 363,424		$ 81	$ (309,214)
Beginning balance (in shares) at Dec. 31, 2021			13,247,000
Beginning balance (in shares) at Dec. 31, 2021				1,004,000
Increase (Decrease) in Equity
Net income (loss)	(42,305)							(42,305)
Foreign currency translation adjustment	100						100
Stock issued under employee stock purchase plan	140				140
Stock issued under employee stock purchase plan (in shares)				(6,591)
Restricted stock granted (in shares)			255,000
Restricted stock forfeited (in shares)			(1,000)	(5,009)
Restricted stock units vested	(31)				(31)
Restricted units vested (in shares)			24,000
Stock compensation expense	3,325				3,325
Shares withheld to cover taxes	(193)			$ (151)	(42)
Shares withheld to cover taxes (in shares)			6,000	19,133
Conversion of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable to February 2023 Warrants	9,930				9,930
Equity contribution	8,400				8,400
Conversion of convertible notes payable to common stock	3,038				3,038
Conversion of convertible notes payable to common stock (in shares)			467,000
Ending balance at Dec. 31, 2022	$ 2,596		$ 1	$ (34,251)	388,184		181	(351,519)
Ending balance (in shares) at Dec. 31, 2022	13,985,986		13,986,000
Ending balance (in shares) at Dec. 31, 2022	1,021,255			1,021,000
Increase (Decrease) in Equity
Net income (loss)	$ 24,713							24,713
Foreign currency translation adjustment	(54)						(54)
Stock issued under employee stock purchase plan	$ 77				77
Stock issued under employee stock purchase plan (in shares)	(20,000)			(20,000)
Restricted stock granted (in shares)			146,000
Restricted stock forfeited (in shares)	(66,000)		(7,000)	(66,000)
Restricted units vested (in shares)			82,000
Forfeited stock options purchased	$ (617)				(617)
Stock compensation expense	(254)				(254)
Shares withheld to cover taxes	(268)			$ (253)	(15)
Shares withheld to cover taxes (in shares)			3,000	42,000
Conversion of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable to February 2023 Warrants		$ 15,092				$ 15,092
Conversion of convertible notes payable to February 2023 Warrants	11,040				11,040
Conversion of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable to common stock	40,638		$ 1		40,637
Conversion of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable to common stock (in shares)			10,583,000
Conversion of convertible notes payable to common stock	8,997		$ 1		8,996
Conversion of convertible notes payable to common stock (in shares)			1,723,000
Other (in shares)			35,000
Exercise of February 2023 warrants (in shares)			4,228,000
Ending balance at Dec. 31, 2023	$ 101,960		$ 3	$ (34,504)	$ 463,140		$ 127	$ (326,806)
Ending balance (in shares) at Dec. 31, 2023	30,772,837		30,773,000
Ending balance (in shares) at Dec. 31, 2023	1,108,707			1,109,000